Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts

Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts

The functional receptor to SARS-CoV-2, the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, is angiotensin-converting enzyme-2 (ACE-2), the same enzyme that physiologically counters the renin-angiotensin system (RAS) activation. Some researchers have questioned RAS inhibitors’...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kunal Mahajan, Prakash Chand Negi, Neeraj Ganju, Sachin Sondhi, Naresh Gaur, Rao Somendra
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2020/1025913
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System
by: Farzaneh Ketabchi, et al.
Published: (2022-01-01)

The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?
by: Wencheng Li, et al.
Published: (2012-01-01)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
by: P. Stiefel, et al.
Published: (2011-01-01)

Local Bone Marrow Renin-Angiotensin System and Atherosclerosis
by: Yavuz Beyazit, et al.
Published: (2011-01-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014-01-01)

Sympathoexcitation Associated with Renin-Angiotensin System in Metabolic Syndrome
by: Takuya Kishi, et al.
Published: (2013-01-01)

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
by: Helena Norberg, et al.
Published: (2019-01-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
by: Alexandre Connolly, et al.
Published: (2018-01-01)

Renin-Angiotensin System and Sympathetic Neurotransmitter Release in the Central Nervous System of Hypertension
by: Kazushi Tsuda
Published: (2012-01-01)

MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
by: Shinji Hagiwara, et al.
Published: (2013-01-01)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
by: Qi Feng, et al.
Published: (2020-01-01)

Renin-Angiotensin System Genes Polymorphisms and Essential Hypertension in Burkina Faso, West Africa
by: Daméhan Tchelougou, et al.
Published: (2015-01-01)

Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen
by: Siew Mei Joyce-Tan, et al.
Published: (2016-01-01)

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
by: Avantika Chenna, et al.
Published: (2020-01-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion
by: Simón Quetzalcóatl Rodríguez-Lara, et al.
Published: (2018-01-01)

Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?
by: Terry S. Elton, et al.
Published: (2010-01-01)

Antioxidant and Renin-Angiotensin System Inhibitory Properties of Cashew Nut and Fluted-Pumpkin Protein Hydrolysates
by: Sunday A. Malomo, et al.
Published: (2020-06-01)

Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study
by: Katharina Krenn, et al.
Published: (2025-01-01)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
by: Yutaka Kawabata, et al.
Published: (2020-01-01)

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
by: Fabrizio Montecucco, et al.
Published: (2009-01-01)

Effects of brain renin- angiotensin system inhibition in ISIAH rats with inherited stress-induced arterial hypertension
by: L. O. Klimov, et al.
Published: (2017-11-01)

Differential Effects of Alcoholic and Non-Alcoholic Beer Intake on Renin–Angiotensin System Modulation in Spontaneous Hypertensive Rats
by: María Dolores Mayas, et al.
Published: (2025-01-01)

Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
by: Molly Moore Jeffery, et al.
Published: (2022-07-01)

Genetic Variants of C-5312T REN Increased Renin Levels and Diastolic Blood Pressure Response to Angiotensin Receptor Blockers
by: Mohammad Saifur Rohman, et al.
Published: (2015-01-01)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01)

Immune Optimization as a Preventive and Therapeutic Adjunct for the Management of Renin–Angiotensin–Aldosterone System Dysfunction Diseases: A Review
by: Michael T. Okafor, et al.
Published: (2024-07-01)

Dose‐exposure‐response of CARDALIS® (benazepril/spironolactone) on the classical and alternative arms of the renin‐angiotensin‐aldosterone system in healthy dogs
by: Elizabeth Manson, et al.
Published: (2025-01-01)

Free Fatty Acids Activate Renin-Angiotensin System in 3T3-L1 Adipocytes through Nuclear Factor-kappa B Pathway
by: Jia Sun, et al.
Published: (2016-01-01)

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
by: Henrik Toft Sørensen, et al.
Published: (2017-01-01)

Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
by: Roda Plakogiannis, et al.
Published: (2025-02-01)

First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients
by: Ibrahim M. Alanazi, et al.
Published: (2025-02-01)

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
by: Wei-Fan Hsu, et al.
Published: (2019-01-01)

Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model
by: María Sánchez-Aguilar, et al.
Published: (2020-01-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
by: Daisuke Watanabe, et al.
Published: (2020-01-01)

Immunohistochemistry for (Pro)renin Receptor in Humans
by: Satoshi Morimoto, et al.
Published: (2021-01-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Regulation of (Pro)Renin Receptor in Renin-Positive Smooth Muscle Cells of Kidney Arterioles in Rats with STZ-Induced Diabetes
by: Zsolt Razga, et al.
Published: (2019-01-01)